APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 2 filers reported holding APTOSE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,392 | +10.3% | 30,300 | 0.0% | 0.00% | – |
| Q4 2022 | $17,574 | -2.4% | 30,300 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | -18.2% | 30,300 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -46.3% | 30,300 | 0.0% | 0.00% | – |
| Q1 2022 | $41,000 | 0.0% | 30,300 | 0.0% | 0.00% | – |
| Q4 2021 | $41,000 | -37.9% | 30,300 | 0.0% | 0.00% | – |
| Q3 2021 | $66,000 | -34.7% | 30,300 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | -44.2% | 30,300 | 0.0% | 0.00% | – |
| Q1 2021 | $181,000 | +36.1% | 30,300 | 0.0% | 0.00% | – |
| Q4 2020 | $133,000 | -26.9% | 30,300 | 0.0% | 0.00% | – |
| Q3 2020 | $182,000 | -4.7% | 30,300 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $191,000 | +6.1% | 30,300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $180,000 | +4.7% | 30,300 | 0.0% | 0.00% | – |
| Q4 2019 | $172,000 | +173.0% | 30,300 | 0.0% | 0.00% | – |
| Q3 2019 | $63,000 | -20.3% | 30,300 | 0.0% | 0.00% | – |
| Q2 2019 | $79,000 | +29.5% | 30,300 | 0.0% | 0.00% | – |
| Q1 2019 | $61,000 | +5.2% | 30,300 | 0.0% | 0.00% | – |
| Q4 2018 | $58,000 | -26.6% | 30,300 | 0.0% | 0.00% | – |
| Q3 2018 | $79,000 | -33.6% | 30,300 | 0.0% | 0.00% | – |
| Q2 2018 | $119,000 | +24.0% | 30,300 | 0.0% | 0.00% | – |
| Q1 2018 | $96,000 | +41.2% | 30,300 | 0.0% | 0.00% | – |
| Q4 2017 | $68,000 | +51.1% | 30,300 | 0.0% | 0.00% | – |
| Q3 2017 | $45,000 | – | 30,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Annandale Capital, LLC | 74,666 | $209 | 0.05% |
| CALDWELL SUTTER CAPITAL, INC. | 92 | $258 | 0.00% |